| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/AID.2010.0169 |
| P8608 | Fatcat ID | release_3txs44akxfffxmooxzer6bmlzm |
| P932 | PMC publication ID | 3132065 |
| P698 | PubMed publication ID | 21091128 |
| P5875 | ResearchGate publication ID | 49622416 |
| P50 | author | Herman Staats | Q42428433 |
| Lucia Lopalco | Q43112481 | ||
| Michael Hoelscher | Q72527439 | ||
| Leonard Maboko | Q72529045 | ||
| Gabriele Riedner | Q76571794 | ||
| Pamela A Kozlowski | Q88438362 | ||
| P2093 | author name string | Jiri Mestecky | |
| Rose Kulhavy | |||
| Zina Moldoveanu | |||
| Claudia Pastori | |||
| Peter F Wright | |||
| Rashada C Alexander | |||
| Terri Wrinn | |||
| Yuwei Zhu | |||
| P2860 | cites work | Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 |
| Codon usage limitation in the expression of HIV-1 envelope glycoprotein | Q24498729 | ||
| In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity | Q28383065 | ||
| Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies | Q29614531 | ||
| Rapid evolution of the neutralizing antibody response to HIV type 1 infection | Q29618603 | ||
| Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects | Q31078772 | ||
| HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis | Q33479955 | ||
| Diversity considerations in HIV-1 vaccine selection | Q34136023 | ||
| Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization | Q34357220 | ||
| Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination | Q34537706 | ||
| Ancestral and consensus envelope immunogens for HIV-1 subtype C. | Q34539222 | ||
| Molecular mechanism of class switch recombination: linkage with somatic hypermutation | Q34542246 | ||
| Humoral immune responses to microbial infections in the genital tract | Q34669747 | ||
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia | Q34848486 | ||
| Methodological lessons from a cohort study of high risk women in Tanzania | Q35577076 | ||
| Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism | Q35635933 | ||
| Immunoglobulin A antibodies against internal HIV-1 proteins neutralize HIV-1 replication inside epithelial cells | Q35636425 | ||
| Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression | Q35849745 | ||
| Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins | Q35933555 | ||
| Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection | Q36095139 | ||
| Immunologic uniqueness of the genital tract: challenge for vaccine development | Q36099546 | ||
| Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women | Q36863855 | ||
| Neutralizing antibodies in mucosal secretions: IgG or IgA? | Q37017811 | ||
| GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium. | Q37063527 | ||
| Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure | Q37344616 | ||
| HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits | Q37444317 | ||
| Decline in sexually transmitted infection prevalence and HIV incidence in female barworkers attending prevention and care services in Mbeya Region, Tanzania | Q37862938 | ||
| Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project. | Q38885690 | ||
| Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells | Q38945636 | ||
| Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays | Q39988991 | ||
| Intraepithelial cell neutralization of HIV-1 replication by IgA. | Q40437934 | ||
| Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. | Q40762424 | ||
| Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients | Q40878140 | ||
| Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques | Q41814443 | ||
| HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers | Q43976669 | ||
| Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia | Q44486781 | ||
| Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects | Q44499821 | ||
| A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men | Q44545899 | ||
| High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. | Q44620120 | ||
| Detection of specific IgA antibodies to varicella zoster virus in serum of patients with Ramsay Hunt syndrome | Q44980411 | ||
| HIV-specific IgG in cervicovaginal secretions of exposed HIV-uninfected female sexual partners of HIV-infected men. | Q45027371 | ||
| Enhanced chemiluminescence as a means of increasing the sensitivity of western blot assays for HIV antibody | Q45056651 | ||
| Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. | Q45729198 | ||
| Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. | Q45731387 | ||
| Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection | Q45744790 | ||
| Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons | Q45747957 | ||
| Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group | Q45752474 | ||
| Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information | Q45762213 | ||
| Human immune responses to influenza virus vaccines administered by systemic or mucosal routes | Q45772716 | ||
| Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection | Q45787391 | ||
| Immunoglobulin A antibody against hepatitis B core antigen in the acute and persistent infection with hepatitis B virus | Q45838118 | ||
| Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection | Q46180015 | ||
| Predominate HIV1-specific IgG activity in various mucosal compartments of HIV1-infected individuals | Q46471105 | ||
| Cervical HIV-specific IgA in a population of commercial sex workers correlates with repeated exposure but not resistance to HIV. | Q46807113 | ||
| Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice | Q47415954 | ||
| HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1-exposed uninfected individuals. | Q51714201 | ||
| Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity. | Q51841750 | ||
| Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding. | Q52025108 | ||
| Nonclassical mucosal antibodies predominate in genital secretions of HIV-1 infected chimpanzees. | Q52846271 | ||
| The ‘immunologic advantage’ of HIV-exposed seronegative individuals | Q57997441 | ||
| Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men | Q57997551 | ||
| Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects | Q57997566 | ||
| Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers | Q57997576 | ||
| HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket | Q57997632 | ||
| HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals | Q57997711 | ||
| Detection of Mucosal Antibodies in HIV Type 1-Infected Individuals | Q58168585 | ||
| [3] Immunoglobulin A (IgA) | Q58234753 | ||
| HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia | Q59661551 | ||
| Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM | Q59705753 | ||
| Quantitation of HIV-1-Specific IgG, IgA, and IgM Antibodies in Human Genital Tract Secretions | Q60686915 | ||
| Degradation of immunoglobulins by secretions of human reproductive tracts | Q67297246 | ||
| Immunoglobulins A, G, and M to Cytomegalovirus during Recurrent Infection in Recipients of Allogeneic Bone Marrow Transplantation | Q67913282 | ||
| Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS | Q71917461 | ||
| Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method | Q72304746 | ||
| Serum IgA-mediated neutralization of HIV type 1 | Q72363613 | ||
| Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children | Q73028942 | ||
| Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation | Q73215687 | ||
| False positivity of enzyme-linked immunosorbent assay for measurement of secretory IgA antibodies directed at HIV type 1 antigens | Q73703199 | ||
| Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients | Q74449425 | ||
| In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA | Q74506178 | ||
| Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals | Q81109508 | ||
| Immune responses that correlate with HIV-1 protection? | Q81612295 | ||
| Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men | Q83124960 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| immunology | Q101929 | ||
| infectious disease | Q18123741 | ||
| P304 | page(s) | 469-486 | |
| P577 | publication date | 2010-11-22 | |
| P1433 | published in | AIDS Research and Human Retroviruses | Q4651880 |
| P1476 | title | Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women | |
| P478 | volume | 27 |
| Q37833671 | A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments |
| Q34737407 | Adaptive HIV-specific B cell-derived humoral immune defenses of the intestinal mucosa in children exposed to HIV via breast-feeding |
| Q36753653 | Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women |
| Q37237797 | Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples |
| Q37180418 | Characterization of serum antibodies from women immunized with Gardasil: A study of HPV-18 infection of primary human keratinocytes |
| Q36547166 | Comparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women |
| Q36150291 | Default in plasma and intestinal IgA responses during acute infection by simian immunodeficiency virus. |
| Q33865785 | Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy |
| Q34034659 | Differential glycosylation of envelope gp120 is associated with differential recognition of HIV-1 by virus-specific antibodies and cell infection |
| Q37854081 | Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). |
| Q36356350 | Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines |
| Q34282935 | HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men. |
| Q33939974 | HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities |
| Q37347345 | HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis |
| Q35192641 | HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies |
| Q33624872 | Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women |
| Q37316629 | Immunotherapies to prevent mother-to-child transmission of HIV |
| Q36487349 | Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8. |
| Q92883468 | Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity |
| Q33911540 | Mucosal correlates of protection in HIV-1-exposed sero-negative persons |
| Q64905315 | Natural Immunity to HIV is associated with Low BLyS/BAFF levels and low frequencies of innate marginal zone like CD1c+ B-cells in the genital tract. |
| Q34044915 | Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally |
| Q34598141 | Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes |
| Q62487341 | Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1 |
| Q34399515 | Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers |
Search more.